Phytotherapy in Streptococcusagalactiae: An Overview of the Medicinal Plants Effective against Streptococcus agalactiae. by Delfani, S. et al.
Journal of Clinical and Diagnostic Research. 2017 Jun, Vol-11(6): DE01-DE02 1












n Phytotherapy in Streptococcus 
agalactiae: An Overview of the 
Medicinal Plants Effective against 
Streptococcus agalactiae
INTRODUCTION
Streptococcus Group B (SGiB) bacteria such as Streptococcus 
agalactiae are the normal flora of the gastrointestinal tract, urogenital 
tract and the genitourinary tract which have been isolated from 
about 35% of healthy adult women [1]. Streptococcus agalactiae 
is a gram- positive and spherical bacterium. The bacterium is also 
the cause of meningitis, infection of the newborn, pneumonia and 
sepsis [2]. The bacterium is colonized in the rectum and the vagina 
of pregnant women and about 2% of newborns are infected with 
Streptococcus agalactiae.
Based on the obtained results and CDC guidelines on screening 
the pregnant women and risk factors, prevalence of Streptococcus 
agalactiae infections in infants has decreased [3-5]. Streptococcus 
agalactiae causes infections of birth sepsis, endometritis, 
chorioamnionitis and premature delivery in pregnant women [1,6]. 
For centuries, the use of herbs and natural ingredients has been 
common for the treatment of various disorders [7-9]. Despite the 
demonstrated antimicrobial effects of some herbal ingredients 
(extracts, essences and alkaloids), their uses in the treatment of 
infections are not common. The present review is a report on the 
medicinal plants with anti-Streptococcus agalactiae effects. This 
study is an overview of the most important medicinal plants affecting 
Streptococcus agalactiae.
For this review, search was carried out by using the keyword such 
as bacteria, Streptococcus agalactiae and medicinal plants. The 
databases used were Web of Science, PubMed, Scopus, Google 
Scholar and Science direct.
According to the search results, 10 medicinal plants are used as 
antibacterials against Streptococcus agalactiae. [Table/Fig-1] 
[10,11]. 
DISCUSSION
S. agalactiae is an asymptomatic colonizer of the gastrointestinal 
human tract, however, in some circumstances, it causes severe 
infections. As with other virulent bacteria, S. agalactiae harbors 
important virulence factors [12,13]. Though, vaccination is 
associated with reduction in disease incidence and prevalence, 
however there is no effective and safe approach for treatment of the 
disease. Therefore, medicinal plants might be beneficial and safe for 
eradication of the bacteria. 
S. agalactiae, other than human infections, can cause mastitis in 
dairy cattle leading to a economic loss for the industry. S. agalactiae 
can also produce acute or subacute febrile diseases in cow, 
diminishing production of milk. Thus, an outbreak affects the dairy 
industry. Hence, in many countries approaches to reduce the impact 
of S. agalactiae have been enforced in recent decades [14,15]. S. 
agalactiae has also been reported in some other animals including 
cats, crocodiles, camels, dogs, seals and dolphins [16]. 
Antibiotic destroys pathogenic bacteria or other microorganisms and 
help the body to better cope with diseases. Natural antibiotics are 
drugs that are extracted from medicinal plants. Natural antibiotics 
cover a wide range. Clinical research shows that oregano oil, garlic, 
etc., are the most effective natural antibiotics that can destroy even 
the most resistant bacteria in the body. Recent studies have also 
shown the beneficial effects of these natural remedies [17,18]. The 
positive effects of these plants has encouraged more people to 
show a positive attitude for herbal medicines [19,20]. 
CONCLUSION
Natural ingredients reduce the risk of complications and have 
beneficial effects. These natural ingredients increase the beneficial 
bacteria and strengthen the immune system. Given that, antibacterial 
effects of medicinal plants mentioned in this review has been proven, 
it is recommended that the main active ingredients of medicinal 
plants be identified and studied further to approve their antimicrobial 
effects and in preparation of new drugs.
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Aerial parts Streptococcus 
agalactiae
 (RITCC1913)
Anti-bacterial effect of flower ethanol extract of the plant through the inhibition 
zone diameter of 40 mm and MIC=1.5 was confirmed. However, the inhibition 
zone diameter of gentamycin was 20 mm as the control.
[10]
Papaveraceae Papaver dubium Aerial parts Streptococcus 
agalactiae
 (RITCC1913)
Anti-bacterial effect of aerial parts ethanol extract of the plant through the 
inhibition zone diameter of 40 mm and MIC=3.125 was confirmed. However, 




Aerial parts Streptococcus 
agalactiae
 (RITCC1913)
Anti-bacterial effect of flower ethanol extract of the plant through the inhibition 
zone diameter of 40 mm and MIC=0.75 was confirmed. However, the inhibition 




Aerial parts Streptococcus 
agalactiae
 (RITCC1913)
Anti-bacterial effect of flower ethanol extract of the plant through the inhibition 
zone diameter of 25 mm and MIC=6.25 was confirmed. However, the inhibition 





Aerial parts Streptococcus 
agalactiae
 (RITCC1913)
Anti-bacterial effect of flower ethanol extract of the plant through the inhibition 
zone diameter of 20 mm and MIC=6.25 was confirmed. However, the inhibition 





Aerial parts Streptococcus 
agalactiae
 (RITCC1913)
Anti-bacterial effect of flower ethanol extract of the plant through the inhibition 
zone diameter of 20 mm and MIC=6.25 was confirmed. However, the inhibition 
zone diameter of gentamycin was 20 mm as the control.
[10]
Basellaceae Anredera diffusa leaf Streptococcus 
agalactiae
 (Group B, ATCC 
13813)
The ethanol extract of the plant with more than 0.7 cm diameter of inhibition 
zone had antibacterial properties. However, the inhibition zone diameter of more 







The ethanol extract of the plant with more than 0.7 cm diameter of inhibition 
zone had antibacterial properties. However, the inhibition zone diameter of more 
than 0.7 cm was reported for vancomycin as a positive control.
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The ethanol extract of the plant with more than 0.7 cm diameter of inhibition 
zone had antibacterial properties. However, the inhibition zone diameter of more 







The ethanol extract of the plant with more than 0.7 cm diameter of inhibition 
zone had antibacterial properties. However, the inhibition zone diameter of more 
than 0.7 cm was reported for vancomycin as a positive control.
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